ADBT lists without an IPO price; 3223 is the live Hong Kong subscription (2026)

Monday, August 17, 2026 is a normal U.S. trading day. The most relevant U.S. event is a Nasdaq listing where the opening price will be discovered in the market, not set by a standard IPO book. 1

Today's spotlight: Advasa Holdings (ADBT)

Status: Expected to begin trading on Nasdaq's Global Market today. ADBT is a direct listing, so there is no disclosed IPO price range, minimum buy-in, or public request window. Existing holders may resell up to 94,046,357 shares. Advasa is not raising new money in that resale, and the filing says the deal is not underwritten. 2 3

Business in one sentence: Advasa runs FUKUPE, a cloud-hosted earned-wage-access platform that lets employees draw wages they have already earned before the normal payday, using employer payroll connections and payment partners. 2

The number to watch: Fiscal-year revenue rose 72.9% to $17.366 million for the year ended March 31, 2026. The company also reported $954,000 of net income. Those figures describe a small, profitable software-and-payments business, not a scaled fintech yet. 2

Risk to monitor: One customer generated 93.6% of fiscal-2026 revenue. The next financial filing is the clean checkpoint: a single customer still above 90% would mean the business remains highly dependent on one relationship. The trading risk is separate. Because there is no traditional IPO price, Nasdaq's opening depends on buy and sell orders; the prospectus says trading can be delayed if the pre-opening interest is insufficient. 2

What this means for a retail investor: ADBT may become buyable through a normal brokerage after it starts trading, but that is secondary-market access. It is not a chance to request IPO shares at a fixed price. The first useful data point is the actual opening price and trading volume, not a headline valuation that the filing never sets.

Actionable now

No U.S. IPO allocation met all four checks for this edition: published offer terms, a live deadline, a minimum buy-in, and a verified path through a mainstream retail broker. ADBT is a direct listing. Lyntris (LYNX) has public terms and an expected Aug. 19 listing, but the reviewed exchange and public-calendar pages do not show a retail allocation notice. 4 5

Ticker	Price range	Minimum buy-in	Deadline	Verified brokers	Status
None verified	—	Not disclosed	No live public allocation found	None publicly verified	Watch only

A normal brokerage order after listing is a different product from an IPO allocation. Keep those two paths separate.

Market pulse

Listed IPOs are outperforming the broad market this year. As of Aug. 13, the Renaissance IPO Index was up 25.6% year to date, versus 14.7% for the S&P 500. That is a backdrop for attention, not proof that a new deal is cheap. 6
The pipeline is still active even as the dated calendar thins out. Renaissance counted seven initial filings in the week of Aug. 10, including SPAC proposals of $312 million, $250 million, and $220 million. Filings show future supply; they do not create a retail order window. 6
Defense technology is the clearest near-term theme. LYNX is the only dated traditional-company U.S. deal on the reviewed week-ahead calendar, while the Nasdaq calendar shows no other scheduled IPOs. Its size and sector make it the name to watch, but its public filing still leaves broker access unverified. 5 7

HK desk

Open today: Beijing Junzheng Integrated Circuit (3223), a Chinese chipmaker focused on memory, computing, and analog products, began its Hong Kong public offer on Aug. 17. The offer closes Aug. 20 at 04:00, corresponding to noon in Hong Kong. The maximum offer price is HK$102.80. One board lot is 100 shares, and the maximum first-lot application amount including stated fees is HK$10,383.68. Expected pricing is Aug. 21, with trading scheduled for Aug. 25. 8 9

The filing also says the global offer is expected to issue 31.2873 million H shares and could raise about HK$3.141 billion after expenses at the maximum price. That is the disclosed capital-raising case; the final price is still pending. 8

On the radar: Aug. 18-31

Deal	Pricing date	Expected listing	Terms	Why watch
Lyntris (LYNX)	Not separately disclosed	Aug. 19, NYSE	24 million shares at $19-$22; about $492 million at the midpoint	A defense-technology roll-up with the largest dated traditional-company deal on the reviewed calendar. The price, final share count, and broker access still need confirmation. 5 7

The public calendars reviewed for the rest of the two-week window do not provide another dated, fully termed traditional U.S. company IPO with a separate pricing date. That makes LYNX a watch item, not an actionable allocation.

Market information only, not investment advice. IPO terms, dates, opening prices, listing plans, and broker access can change.